Clinical Trial Update: A Two-cohort Study of SHR-A1811 in the Treatment of HER2-positive Breast Cancer With Brain Metastases [Phase 1, Phase 2]

View source ↗

Summary

This is a two-cohort Phase 1/Phase 2 study evaluating SHR-A1811 for HER2-positive breast cancer with brain metastases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Breast Cancer
• Leptomeningeal Metastasis

Drugs mentioned

• SHR-A1811

Snippet

Sponsor: Peking University Cancer Hospital & Institute | Conditions: Breast Cancer, Brain Metastases | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING